Nektar Therapeutics Earnings Per Share, Basic and Diluted
Nektar Therapeutics (NKTR) reported Earnings Per Share, Basic and Diluted of -$0.68 per share for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-07.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-05-07
- Nektar Therapeutics earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.68.
- Nektar Therapeutics earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.61.
- Nektar Therapeutics earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.45.
- Nektar Therapeutics earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.78.
- Nektar Therapeutics earnings per share, basic and diluted for fiscal 2017 was -$0.62.
- Nektar Therapeutics earnings per share, basic and diluted for fiscal 2016 was -$1.10.
- Nektar Therapeutics earnings per share, basic and diluted for fiscal 2015 was -$0.61.
- Nektar Therapeutics earnings per share, basic and diluted for fiscal 2014 was -$0.42.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|
| 2021-03-31 | -$0.68 10-Q · filed 2021-05-07 | ||||
| 2020-09-30 | -$0.61 10-Q · filed 2020-11-06 | -$1.06 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$1.84 10-Q · filed 2020-11-06 | ||
| 2020-06-30 | -$0.45 10-Q · filed 2020-08-07 | -$1.23 10-Q · filed 2020-08-07 | |||
| 2020-03-31 | -$0.78 10-Q · filed 2021-05-07 | ||||
| 2019-09-30 | -$0.56 10-Q · filed 2020-11-06 | -$1.19 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$1.88 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | -$0.63 10-Q · filed 2020-08-07 | -$1.32 10-Q · filed 2020-08-07 | |||
| 2019-03-31 | -$0.69 10-Q · filed 2020-05-08 | -$0.68 10-Q · filed 2019-05-09 | |||
| 2018-03-31 | -$0.60 10-Q · filed 2019-05-09 | ||||
| 2017-12-31 | -$0.62 10-K · filed 2018-03-01 | ||||
| 2017-06-30 | -$0.39 10-Q · filed 2017-08-09 | -$0.80 10-Q · filed 2017-08-09 | -$1.09 derived: net income ÷ weighted average shares · filed 2019-03-01 | -$1.41 derived: net income ÷ weighted average shares · filed 2019-03-01 | |
| 2017-03-31 | -$0.42 10-Q · filed 2018-05-10 | -$0.70 derived: net income ÷ weighted average shares · filed 2019-03-01 | -$1.02 derived: net income ÷ weighted average shares · filed 2019-03-01 | -$1.37 derived: net income ÷ weighted average shares · filed 2019-03-01 | |
| 2016-12-31 | -$0.28 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$0.60 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$0.95 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$1.10 10-K · filed 2018-03-01 | |
| 2016-09-30 | -$0.32 10-Q · filed 2016-11-04 | -$0.67 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$0.82 10-Q · filed 2016-11-04 | -$1.22 derived: net income ÷ weighted average shares · filed 2018-03-01 | |
| 2016-06-30 | -$0.36 10-Q · filed 2017-08-09 | -$0.50 10-Q · filed 2017-08-09 | -$0.90 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$0.97 derived: net income ÷ weighted average shares · filed 2018-03-01 | |
| 2016-03-31 | -$0.14 10-Q · filed 2017-05-10 | -$0.55 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$0.61 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$1.01 derived: net income ÷ weighted average shares · filed 2018-03-01 | |
| 2015-12-31 | -$0.40 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$0.47 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$0.87 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$0.61 10-K · filed 2018-03-01 | |
| 2015-09-30 | -$0.06 10-Q · filed 2016-11-04 | -$0.46 derived: net income ÷ weighted average shares · filed 2017-03-01 | -$0.21 10-Q · filed 2016-11-04 | ||
| 2015-06-30 | -$0.40 10-Q · filed 2016-08-04 | -$0.14 10-Q · filed 2016-08-04 | |||
| 2014-12-31 | -$0.42 10-K · filed 2017-03-01 | ||||
| 2014-06-30 | -$0.26 10-Q · filed 2015-08-06 | -$0.63 10-Q · filed 2015-08-06 | -$1.03 derived: net income ÷ weighted average shares · filed 2016-02-29 | -$1.19 derived: net income ÷ weighted average shares · filed 2016-02-29 | |
| 2014-03-31 | -$0.37 10-Q · filed 2014-05-08 | -$0.78 derived: net income ÷ weighted average shares · filed 2016-02-29 | -$0.93 derived: net income ÷ weighted average shares · filed 2016-02-29 | -$1.30 derived: net income ÷ weighted average shares · filed 2016-02-29 | |
| 2013-12-31 | -$0.41 10-K · filed 2014-02-27 | -$0.55 derived: net income ÷ weighted average shares · filed 2016-02-29 | -$0.92 derived: net income ÷ weighted average shares · filed 2016-02-29 | -$1.40 10-K · filed 2016-02-29 | |
| 2013-09-30 | -$0.14 10-K · filed 2014-02-27 | -$0.51 derived: net income ÷ weighted average shares · filed 2015-02-26 | -$0.99 10-Q · filed 2013-11-07 | -$1.45 derived: net income ÷ weighted average shares · filed 2015-02-26 | |
| 2013-06-30 | -$0.37 10-Q · filed 2014-08-01 | -$0.85 10-Q · filed 2014-08-01 | -$1.31 derived: net income ÷ weighted average shares · filed 2015-02-26 | -$1.69 derived: net income ÷ weighted average shares · filed 2015-02-26 | |
| 2013-03-31 | -$0.48 10-Q · filed 2014-05-08 | -$0.94 derived: net income ÷ weighted average shares · filed 2015-02-26 | -$1.32 derived: net income ÷ weighted average shares · filed 2015-02-26 | -$1.62 derived: net income ÷ weighted average shares · filed 2015-02-26 | |
| 2012-12-31 | -$0.46 10-K · filed 2014-02-27 | -$0.84 derived: net income ÷ weighted average shares · filed 2015-02-26 | -$1.14 derived: net income ÷ weighted average shares · filed 2015-02-26 | -$1.50 10-K · filed 2015-02-26 | |
| 2012-09-30 | -$0.38 10-K · filed 2014-02-27 | -$0.68 derived: net income ÷ weighted average shares · filed 2014-02-27 | -$1.04 10-Q · filed 2013-11-07 | ||
| 2012-06-30 | -$0.30 10-K · filed 2014-02-27 | -$0.66 10-Q · filed 2013-08-09 | |||
| 2012-03-31 | -$0.36 10-K · filed 2014-02-27 | ||||
| 2011-12-31 | -$0.33 10-K · filed 2013-03-01 | -$1.19 10-K · filed 2014-02-27 | |||
| 2011-09-30 | -$0.21 10-K · filed 2013-03-01 | -$0.86 10-Q · filed 2012-11-09 | |||
| 2011-06-30 | -$0.32 10-K · filed 2013-03-01 | -$0.65 10-Q · filed 2012-08-09 | |||
| 2011-03-31 | -$0.33 10-K · filed 2013-03-01 | ||||
| 2010-12-31 | -$0.24 10-K · filed 2012-02-29 | -$0.40 10-K · filed 2013-03-01 | |||
| 2010-09-30 | -$0.09 10-K · filed 2012-02-29 | ||||
| 2010-06-30 | -$0.01 10-K · filed 2012-02-29 | ||||
| 2010-03-31 | -$0.07 10-K · filed 2012-02-29 | ||||
| 2009-12-31 | -$1.11 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |